Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Intravenous Pantoloc in aspirin-induced ulcer bleeding

Trial Profile

Intravenous Pantoloc in aspirin-induced ulcer bleeding

Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2009

At a glance

  • Drugs Pantoprazole (Primary)
  • Indications Cardiovascular disorders; Cerebrovascular disorders; Embolism and thrombosis
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Dec 2009 Results published in Annals of Internal Medicine.
    • 20 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top